GlassScriptPhysician profile
Anthony J Squillaro
NPI 1740289875
$6,569.77
in general payments reported to CMS, 2019-2025
13 companies · $601 in 2025
The $601 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,843 · 2020: $161 · 2022: $3,154 · 2023: $475 · 2024: $336 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923 · Travel and Lodging: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.24 |
| Travel and Lodging | $488.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,599.62 | 2019-2022 | |
| Nuvasive, INC. | $1,450.65 | 2019 | |
| Ethicon INC. | $488.18 | 2025 | |
| Stryker Corporation | $478.00 | 2022 | |
| Tactile Systems Technology INC | $398.16 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic Vascular, INC. | $343.25 | 2019-2020 | |
| Davol INC. | $159.57 | 2023 | Phasix Mesh |
| Boston Scientific Corporation | $142.90 | 2023 | Varithena Administration Pack |
| Medtronic, INC. | $133.65 | 2024 | Venaseal |
| W. L. Gore & Associates, INC. | $110.71 | 2019-2020 | |
| Ethicon US, LLC | $105.42 | 2022-2025 | Echelon Circular |
| Innocoll Pharmaceuticals Limited | $97.77 | 2022 | |
| Axonics, INC. | $61.89 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Squillaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.